Neurobiological Technologies, Inc.

Neurobiological Technologies, Inc.

NTII - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$2.7K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Neurobiological Technologies, Inc.Neurobiological Technologies, Inc.0-39%--

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$2,702.00
Enterprise Value$-9,484,298.00
Earnings per Share$0.12
Beta7.38
Outstanding Shares26,930,000

Return

Return on Equity38.76%ROE
Return on Assets37.91%
Return on Invested Capital39.44%

Valuation & Multiples

P/E Ratio0P/E Ratio
PEG0PEG
Price to Sales0.0Price to Sales
Price to Book Ratio0.0Price to Book Ratio
Enterprise Value to Revenue-0.33
Enterprise Value to EBIT-0.83
Enterprise Value to Net Income-1
Total Debt to Enterprise-0.01
Debt to Equity0Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Neurobiological Technologies, Inc.

4 employees
CEO: John B. Stuppin

Neurobiological Technologies, Inc. (NTII) is currently undergoing a liquidation and dissolution process, a plan that received stockholder endorsement in October 2009. In its earlier operations, the company's core focus was on the develop...